Tustin-based AMDL Inc., developer and marketer of tests for the early detection of cancer and other serious diseases, said the South Korean company MyGene Inc., has announced it has won approval from its government to market AMDL’s unique DR-70 cancer diagnostic test kit in that nation.

MyGene is affiliated with approximately 100 medical centers in South Korea, which has a population of close to 50 million people, and currently markets a unique test for human papilloma virus for cervical cancer, as well as BRC1 and BRC2 for breast cancer.

“MyGene is well respected throughout the South Korean medical community,” said Gary Dreher, AMDL CEO. “South Korea is a nation of more than 50 million people and we are pleased that MyGene will be distributing our flagship product in this important southeastern Asian country.”

Posted on January 28, 2007 02:50 PM